← Back to headlines
FDA Reverses Course, Will Review Moderna's Flu Shot
The FDA has reversed its previous decision and will now review Moderna's flu shot, indicating a potential advancement in the vaccine market.
18 Feb, 19:59 — 18 Feb, 19:59
The FDA has reversed its previous decision and will now review Moderna's flu shot, indicating a potential advancement in the vaccine market.
18 Feb, 19:59 — 18 Feb, 19:59
